This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Kyoto University, National Cancer Center, Otsuka Pharmaceutical Company, Limited. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 870 
1 out of 263 
1 out of 846 
Years Active: 2021
Title: Kazuhiko Aoyagi: Innovator in Chemoradiotherapy Evaluation
Introduction
Kazuhiko Aoyagi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical research, particularly in the evaluation of chemoradiotherapy for cancer treatment. His work is essential for improving therapeutic strategies against squamous cell carcinoma.
Latest Patents
Kazuhiko Aoyagi holds a patent titled "Method for evaluating efficacy of chemoradiotherapy against squamous cell carcinoma." This innovative method involves a series of steps designed to assess the effectiveness of chemoradiotherapy in treating this specific type of cancer. His patent is a valuable addition to the medical field, providing a framework for better treatment evaluation.
Career Highlights
Throughout his career, Aoyagi has worked with prestigious institutions such as the National Cancer Center and Kyoto University. His experience in these organizations has allowed him to collaborate with leading experts in cancer research and treatment.
Collaborations
Kazuhiko Aoyagi has collaborated with notable colleagues, including Hiroki Sasaki and Manabu Muto. Their combined expertise has contributed to advancements in cancer treatment methodologies.
Conclusion
Kazuhiko Aoyagi's contributions to the evaluation of chemoradiotherapy highlight his role as an important figure in medical innovation. His patent and collaborations reflect his commitment to improving cancer treatment outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile